Unum Group (UNM) Strikes Fortitude Re Deal, Is It Still Below Fair Value?

مجموعة أونم

Unum Group

UNM

0.00

Why Unum Group stock is in focus after the Fortitude Re deal

Unum Group (UNM) has drawn fresh attention after announcing a long term care reinsurance agreement with Fortitude Re that covers US$3.8b of statutory reserves tied to roughly 50,000 individual policies.

The move is part of Unum Group’s ongoing closed block risk reduction plan. This transaction and a prior 2025 deal together transfer more than US$7b of long term care statutory reserves through external reinsurance arrangements.

Against this long term care reinsurance backdrop, Unum Group’s share price has eased 3.1% over the past day but remains higher over the past month and quarter, with a 12.2% one year total shareholder return and very strong five year gains.

If you are weighing how this insurance risk transfer story compares with other opportunities, it can help to set Unum Group alongside a broader group of high quality businesses by scanning the 20 top founder-led companies

Unum Group now trades at a double discount, roughly 46% to one intrinsic estimate and about 10% to analyst targets, just as it sheds more legacy long term care risk. Is the market’s caution still warranted?

Most Popular Narrative: 8.3% Undervalued

The most followed narrative on Unum Group compares a fair value of $97.62 to the last close of $89.51, framing the stock as modestly undervalued based on discounted future cash flows using a 7.11% discount rate.

Strategic derisking of the legacy long-term care (LTC) block through external reinsurance transactions is freeing up capital, reducing earnings volatility, and allowing management to focus on more profitable and capital-efficient core businesses, supporting steadier net income and increased share repurchases.

The fair value call rests on a tight set of assumptions: flat top line, a sharply higher profit margin, and a future earnings multiple that slips below today’s sector average. Want to see how those pieces are stitched together in the full Unum Group narrative?

Result: Fair Value of $97.62 (UNDERVALUED)

However, Unum Group still faces potential pressure if benefit ratios stay elevated or if long term care claims in the Closed Block require further reserve strengthening.

Another View: Unum Group on Earnings Multiples

While the Unum Group narrative leans on discounted cash flows to argue the stock looks modestly undervalued, the current P/E of 18.3x tells a different story. It stands above the US Insurance industry at 12.4x, peers at 17.4x, and a fair ratio of 14.6x. This comparison points to valuation risk if sentiment cools.

If you prefer to compare Unum Group using earnings multiples rather than cash flow models, it can be useful to see how the current P/E sits against a fair ratio and sector averages in more depth. You can then decide which approach you trust more for your own process. See what the numbers say about this price — find out in our valuation breakdown.

NYSE:UNM P/E Ratio as at Jul 2026
NYSE:UNM P/E Ratio as at Jul 2026

Next Steps

With both upside potential and ongoing risks in the Unum Group story, it may be helpful to move quickly and weigh the evidence yourself using the 3 key rewards and 2 important warning signs

Looking for more investment ideas beyond Unum Group?

If you are serious about building a stronger portfolio, do not stop at Unum Group. Use the Simply Wall Street Screener to uncover more targeted opportunities.

  • Zero in on value by reviewing companies that look attractively priced relative to quality using the 41 high quality undervalued stocks
  • Strengthen your income stream by finding companies with substantial yields and resilient payouts through the 8 dividend fortresses
  • Prioritise resilience by focusing on companies with low risk profiles and steadier characteristics via the 74 resilient stocks with low risk scores

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.